Farallon Capital Management, L.L.C. - 13D/13G Filings

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Goto 0, 1, 2, 3, Next
Reported
DateTime
Transaction
Date
TypeCompany
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev ReportView
2026-11-16
09:03 am
Sale
2026-09-3013GTANGO THERAPEUTICS INC
TNGX
Farallon Capital Management, L.L.C.8,543,875
4.900%
-7,726,312decrease
(-47.49%)
Filing
History
2026-11-16
09:01 am
Sale
2026-09-3013GPERSPECTIVE THERAPEUTICS, INC.
CATX
Farallon Capital Management, L.L.C.3,111,254
4.800%
-2,472,225decrease
(-44.28%)
Filing
History
2026-11-16
08:50 am
Sale
2026-09-3013GENANTA PHARMACEUTICALS INC
ENTA
Farallon Capital Management, L.L.C.950,000
3.300%
-1,468,202decrease
(-60.71%)
Filing
History
2026-11-13
08:48 am
Purchase
2026-09-3013GAVALO THERAPEUTICS INC PAR
AVTX
Farallon Capital Management, L.L.C.3,974,000
7.400%
3,974,000increase
(New Position)
Filing
History
2026-11-12
07:34 am
Sale
2026-09-3013GCRINETICS PHARMACEUTICALS INC
CRNX
Farallon Capital Management, L.L.C.0
0.000%
-8,989,098decrease
(Position Closed)
Filing
History
2026-11-12
07:32 am
Purchase
2026-09-3013GBRIDGEBIO PHARMA INC
BBIO
Farallon Capital Management, L.L.C.14,247,000
7.300%
3,503,937increase
(+32.62%)
Filing
History
2026-11-09
7:13 pm
Purchase
2026-11-0913GEXELIXIS INC
EXEL
Farallon Capital Management, L.L.C.14,694,910
6.000%
2,677,004increase
(+22.28%)
Filing
History
2026-11-09
7:10 pm
Sale
2026-11-0613DEXELIXIS INC
EXEL
Farallon Capital Management, L.L.C.12,017,906
4.900%
-1,971,104decrease
(-14.09%)
Filing
History
2026-08-14
08:24 am
Purchase
2026-06-3013GTYRA BIOSCIENCES INC
TYRA
Farallon Capital Management, L.L.C.6,000
0.000%
6,000increase
(New Position)
Filing
History
2026-08-14
08:23 am
Purchase
2026-06-3013GTANGO THERAPEUTICS INC
TNGX
Farallon Capital Management, L.L.C.16,270,187
9.800%
16,270,187increase
(New Position)
Filing
History
2026-08-14
08:23 am
Purchase
2026-06-3013GSAVARA INC
SVRA
Farallon Capital Management, L.L.C.15,000,000
6.800%
3,224,368increase
(+27.38%)
Filing
History
2026-08-14
08:22 am
Purchase
2026-06-3013GINFLARX N V COM
IFRX
Farallon Capital Management, L.L.C.3,325,000
2.300%
3,325,000increase
(New Position)
Filing
History
2026-08-14
08:21 am
Purchase
2026-08-1413DEXELIXIS INC
EXEL
Farallon Capital Management, L.L.C.13,989,010
5.600%
13,989,010increase
(New Position)
Filing
History
2026-08-14
08:19 am
Purchase
2026-06-3013GENANTA PHARMACEUTICALS INC
ENTA
Farallon Capital Management, L.L.C.2,418,202
8.300%
844,373increase
(+53.65%)
Filing
History
2026-08-13
5:20 pm
Purchase
2026-06-3013GREVOLUTION MEDICINES INC
RVMD
Farallon Capital Management, L.L.C.13,564,149
6.400%
13,564,149increase
(New Position)
Filing
History
2026-08-13
5:18 pm
Purchase
2026-06-3013GPROTAGONIST THERAPEUTICS INC C
PTGX
Farallon Capital Management, L.L.C.6,433,119
9.990%
3,015,985increase
(+88.26%)
Filing
History
2026-08-13
5:17 pm
Purchase
2026-06-3013GMINERVA NEUROSCIENCES INC
NERV
Farallon Capital Management, L.L.C.4,730,000
9.700%
4,730,000increase
(New Position)
Filing
History
2026-08-13
5:16 pm
Purchase
2026-06-3013GPERSPECTIVE THERAPEUTICS, INC.
CATX
Farallon Capital Management, L.L.C.5,583,479
8.600%
5,583,479increase
(New Position)
Filing
History
2026-08-13
5:14 pm
Purchase
2026-06-3013GGRAIL INC
GRAL
Farallon Capital Management, L.L.C.4,161,584
9.600%
4,161,584increase
(New Position)
Filing
History
2026-08-13
5:13 pm
Purchase
2026-06-3013GBEAM THERAPEUTICS INC
BEAM
Farallon Capital Management, L.L.C.10,282,210
9.990%
10,282,210increase
(New Position)
Filing
History
Goto 0, 1, 2, 3, Next